ROYALTY PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.41 USD | +3.87% |
|
+2.97% | -2.42% |
| May. 28 | Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday | MT |
| May. 28 | Agios Pharmaceuticals to Sell 15% Vorasidenib Royalty Rights to Royalty Pharma for $905 Million | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.36B | ||||||
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
- Stock Market
- Equities
- RPRX Stock
- Charts Royalty Pharma plc
- Sector Chart
